Specifically, Ma et al. [163] recently found that WTAP increases the m6A level of dual-specific phosphatase 6 (DUSP6) mRNA in an m6A-dependent manner, thereby enhancing its expression and ultimately causing the oncogenic effects of NKTCL. The gene discussed is DUSP6; the disease is extranodal nasal NK/T cell lymphoma.